Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysis
HER2-low TNBC demonstrated unique clinical, transcriptomic and genomic characteristics when contrasted with HER2-0 TNBC. In the LAR subtype, a clear molecular and prognostic discrepancy between HER2-0 and HER2-low tumors was identified.
Authors
- Yinlong Yang (ORCID: https://orcid.org/0000-0001-6721-3850)
- Liangwei Pan
- Wenzhe Zhou (ORCID: https://orcid.org/0000-0002-5236-2279)
- Zhimin Shao
Institutions
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- The Breast
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.breast.2025.104584
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09